Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Chromosomal disorder in which chromosome 22 is affected.
Biomarker and diagnostic research for chromosome 22 disorder has been reported in the published literature.
No clinical trials have been registered for chromosome 22 disorder.
201 publications have been identified in PubMed for chromosome 22 disorder. Research spans Clinical Trial Publication (25%), Review / Meta-Analysis (21%), and Basic Science / Preclinical (21%).
Research Type | Count | % of Total |
|---|---|---|
Clinical study results | 43 | 25% |
Data assembled from 2 of 12 sources · Last updated Sep 20, 2026, 3:03 AM UTC
Common questions about chromosome 22 disorder
35 |
21% |
Laboratory research | 35 | 21% |
Disease patterns and progression | 28 | 16% |
Patient case studies | 21 | 12% |
Testing and diagnosis research | 5 | 3% |
New treatment approaches | 2 | 1% |
Other research | 1 | 1% |
Nishiwaki S (2026). [PMID: 40864405](https://pubmed.ncbi.nlm.nih.gov/40864405/). *International journal of hematology*. [Clinical Trial Publication]
Zahra T (2026). [PMID: 41632382](https://pubmed.ncbi.nlm.nih.gov/41632382/). *Curr Hematol Malig Rep*. [Review / Meta-Analysis]
Weisensee K (2026). [PMID: 41706026](https://pubmed.ncbi.nlm.nih.gov/41706026/). *Clin Genet*. [Basic Science / Preclinical]
Yu J (2026). [PMID: 41776492](https://pubmed.ncbi.nlm.nih.gov/41776492/). *BMC Med*. [Clinical Trial Publication]
Firn K (2026). [PMID: 40465813](https://pubmed.ncbi.nlm.nih.gov/40465813/). *Unknown Journal*. [Basic Science / Preclinical]
Pourhassan H (2026). [PMID: 41144606](https://pubmed.ncbi.nlm.nih.gov/41144606/). *Acta Haematol*. [Review / Meta-Analysis]
Fero H (2026). [PMID: 41320605](https://pubmed.ncbi.nlm.nih.gov/41320605/). *Clin Lymphoma Myeloma Leuk*. [Review / Meta-Analysis]
Mendez LM (2026). [PMID: 40494331](https://pubmed.ncbi.nlm.nih.gov/40494331/). *Acta haematologica*. [Clinical Trial Publication]
Torrent A (2026). [PMID: 40555197](https://pubmed.ncbi.nlm.nih.gov/40555197/). *Acta haematologica*. [Clinical Trial Publication]
Tseng TC (2026). [PMID: 41027807](https://pubmed.ncbi.nlm.nih.gov/41027807/). *Clinical lymphoma, myeloma & leukemia*. [Clinical Trial Publication]